Your session is about to expire
← Back to Search
CTR-US for Carpal Tunnel Syndrome (MISSION Trial)
N/A
Recruiting
Led By Victor M Marwin, MD, MBA
Research Sponsored by Sonex Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
MISSION Trial Summary
Multicenter prospective registry of patients with symptomatic Carpal Tunnel Syndrome treated with Ultrasound Guided Carpal Tunnel Release (CTR-US).
Eligible Conditions
- Carpal Tunnel Syndrome
- CT Scan
MISSION Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Boston Carpal Tunnel Questionnaire - Symptom Severity Scale (BCTQ-SSS)
Secondary outcome measures
Boston Carpal Tunnel Questionnaire - Functional Status Scale (BCTQ-FSS)
Device and/or Procedure Related Adverse Events
EuroQoL 5-Dimension 5-Level (EQ-5D-5L)
+4 moreMISSION Trial Design
1Treatment groups
Experimental Treatment
Group I: CTR-USExperimental Treatment1 Intervention
Ultrasound Guided Carpal Tunnel Release (CTR-US)
Find a Location
Who is running the clinical trial?
Sonex Health, Inc.Lead Sponsor
3 Previous Clinical Trials
682 Total Patients Enrolled
3 Trials studying Carpal Tunnel Syndrome
682 Patients Enrolled for Carpal Tunnel Syndrome
Victor M Marwin, MD, MBAPrincipal InvestigatorBluegrass Orthopaedics
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger